Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02386228 · ClinicalTrials.gov registry record
Micro Ribonucleic Acid (miRNA) Markers of Hydrocephalus in Intraventricular Hemorrhage (IVH)
A clinical trial, sponsored by St. Joseph's Hospital and Medical Center, Phoenix.
- Terminated
- Registry status
- 1
- Enrollment target
NCT02386228 is a clinical trial that was terminated before completion, run by St. Joseph's Hospital and Medical Center, Phoenix. The registered enrollment target is 1 participants.
The verdict
NCT02386228 was terminated before completion, sponsored by St. Joseph's Hospital and Medical Center, Phoenix.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
A collection of biological samples (cerebrospinal fluid \[CSF\] and blood) from patients under 6 years of age who are diagnosed with intraventricular hemorrhage or spina bifida.
Interventions
- GENETIC collection of CSF and blood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2015-03 |
| Est. Completion | 2016-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02386228
The ClinicalTrials.gov registry entry for NCT02386228 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Joseph's Hospital and Medical Center, Phoenix, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which collection of CSF and blood is the first listed.
NCT02386228 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02386228 about?
NCT02386228 is a clinical study titled "Micro Ribonucleic Acid (miRNA) Markers of Hydrocephalus in Intraventricular Hemorrhage (IVH)". A collection of biological samples (cerebrospinal fluid \[CSF\] and blood) from patients under 6 years of age who are diagnosed with intraventricular hemorrhage or spina bifida.
What is the current status of trial NCT02386228?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2015-03. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02386228?
The interventions under investigation include: collection of CSF and blood (GENETIC).
Who is sponsoring clinical trial NCT02386228?
This trial is sponsored by St. Joseph's Hospital and Medical Center, Phoenix, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.